We are monitoring the impact of COVID-19 on Europe BBB Technologies Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 4433
Share on
Share on

Europe Blood Brain Barrier Technologies Market By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2020 to 2025)

Pulished: February, 2020
ID: 4433
Pages: 145

The European Blood-Brain Barrier Technologies Market is estimated to grow at a promising CAGR during the forecast period. 

The Brain is one of the most extensive and most intricate organs in the human body. It consists of 100 billion nerves that communicate with 100 trillion synapses. It is made up of midbrain, hindbrain, and forebrain. It is responsible for movement and thought produced by the body. It has its security system- a filtering mechanism consisting of blood vessels that allow entry of essential nutrients while blocking other substances known as the blood-brain barrier. The blood-brain barrier is a semi-permeable dynamic interface that separates the capillaries that carry blood to the brain and spinal cord tissue by blocking certain substances' passage. It is formed by highly specialized endothelial cells. The blood-brain barrier vessels are made up of specialized endothelial cells, which line brain capillaries from the vascular system, which lack the fenestration of pores and allow rapid exchange of molecules between vessels and tissues. The blood-brain barrier protects the neural tissue from harmful chemicals and maintains a stable environment. However, this barrier is so effective at blocking the entry of foreign substances that it often prevents penetration of life-saving drugs to address issues like injuries and diseases. Therefore, the discovery of new methods allowing the effective delivery of medicines and bio-macromolecules to the central nervous system (CNS) is of immense importance for the treatment of neurodegenerative disorders. Neurodegeneration and neuroinflammation are significant events in CNS disorders like Parkinson's disease, stroke, Alzheimer's disease, and multiple sclerosis. But still, the drugs for CNS treatment, like neurotrophic factors, including BDNF, EPO (erythropoietin), and anti-inflammatory antibodies (e.g., Enbrel and Remicade), do not cross the blood-brain barrier in adequate therapeutic quantities.

Growing prevalence of neurological diseases like Parkinson’s disease, meningitis, multiple sclerosis, and encephalitis, augmenting geriatric population, rising healthcare expenditure, increasing investment in R&D for the development of new drugs and delivery devices, growing awareness about healthcare, and an increasing number of initiatives by various governments and affiliated associations are few key factors driving the growth of the market.

On the other hand, intricate regulatory frameworks for the approval of drugs in most countries and inordinate approval time for drugs due to the brain's insufficient knowledge are primary restraints for the growth of the market.

The market is segmented into the UK, Spain, Germany, France, and others by geography.

Key players in the market are Bristol-Myers Squibb Company, Pfizer, Inc., biOasia Technologies, Inc., Cypress Biosciences, Inc., Janssen Pharmaceutical N.V., Teva Pharmaceuticals Industries, Ltd., F. Hoffmann La-Roche, Ltd., Eli Lilly and Company, Fabre-Kramer Pharmaceuticals, Inc., NeuroVive Pharmaceutical AB, and ArmaGen.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Geography                 

                                5.1.1 Introduction           

                                5.1.2 Europe      

                                                5.1.2.1 UK

                                                5.1.2.2 Spain

                                                5.1.2.3 Germany

                                                5.1.2.4 France

                                                5.1.2.5 Others

                                5.1.3  Y-o-Y Growth Analysis, By Geography        

                                5.1.4  Market Attractiveness Analysis, By Geography      

                                5.1.5  Market Share Analysis, By Geography       

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Allon Therapeutics, Inc.                         

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 AngioChem Inc.                        

                8.3 Genzyme                    

                8.4 CeNeRx BioPharma, Inc                        

                8.5 Bioasis Technologies Inc.                      

                8.6 Ablynx NV                   

                8.7 Capsulution Pharma AG                        

                8.8 International Brain Barriers Society (IBBS)                     

                8.9 Cephalon Inc                              

                8.10 Cognition Pharmaceuticals LLC                         

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms by type, packaging and meat type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the North america market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Blood Brain Barrier Technologies Market, By Geography, From 2020 to 2025 (USD Million)
  2. Europe BBB Technologies Market, By Region, From 2020 to 2025 (USD Million)
  3. Europe BBB Technologies Market, By Region, From 2020 to 2025 (USD Million)
  4. Europe BBB Technologies Market, By Region, From 2020 to 2025 (USD Million)
  5. Europe BBB Technologies Market, By Region, From 2020 to 2025 (USD Million)
  6. Europe BBB Technologies Market, By Region, From 2020 to 2025 (USD Million)
  7. U.K. Blood Brain Barrier Technologies Market, By Geography, From 2020 to 2025 (USD Million)
  8. Germany Blood Brain Barrier Technologies Market, By Geography, From 2020 to 2025 (USD Million)
  9. France Blood Brain Barrier Technologies Market, By Geography, From 2020 to 2025 (USD Million)
  10. Italy Blood Brain Barrier Technologies Market, By Geography, From 2020 to 2025 (USD Million)
  11. Spain Blood Brain Barrier Technologies Market, By Geography, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample